Patent expiration of intravenous (IV) ibuprofen products is expected to face lower-cost generic competition, which can significantly impact the revenues of existing intravenous (IV) ibuprofen players. This may lead to loss of market share for branded products.
Market Opportunities – Increasing Number of Orthopedic Surgeries
There is an increasing number of orthopedic surgeries being conducted minimally invasively such as arthroscopic and endoscopic procedures. Such surgeries require intravenous anti-inflammatory drugs like ibuprofen for post-operative pain management. This rising trend can boost the demand for intravenous (IV) formulation of ibuprofen.
Intravenous (IV) Ibuprofen Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients